Anticoagulants


October 1, 2012
434 Pages - SKU: GJOB4921030
License type:
The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices)
5/8/2013 | published by: Kalorama Information
The World Market for Catheters (Cardiovascular, Urological, Intravenous and Specialty Devices) Catheters make it possible to drain or inject fluids or enable access to the body  |  read more...
$3,500.00
Mixed Dyslipidemia – Pipeline Review, H1 2013
5/27/2013 | published by: Global Markets Direct
Mixed Dyslipidemia – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Mixed Dyslipidemia - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Mixed Dyslipidemia,  |  read more...
$2,000.00
Cardiovascular Risk Factors – Pipeline Review, H1 2013
5/27/2013 | published by: Global Markets Direct
Cardiovascular Risk Factors – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Cardiovascular Risk Factors - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Heart Transplantation – Pipeline Review, H1 2013
5/27/2013 | published by: Global Markets Direct
Heart Transplantation – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Heart Transplantation - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Heart Transplantation,  |  read more...
$2,000.00
Biomaterials Market [By Products (Polymers, Metals, Ceramics, Natural Biomaterials) & Applications (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurology Disorders)] – Global Forecasts to 2017
3/28/2013 | published by: MarketsandMarkets
A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems. It traces its history to more than 2000 years ago, when Romans,  |  read more...
$4,650.00
Tele-Care Medical Equipment: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2019
3/28/2013 | published by: WinterGreen Research
Tele-Care Medical Equipment: Market Shares, Strategies, and Forecasts, Worldwide, 2013 to 2019 - WinterGreen Research announces that it has a new study on Tele-care equipment Monitoring Market Shares and Forecasts, Worldwide, 2013-2019. The 2013 study  |  read more...
$3,800.00
Other Hematological Disorders – Pipeline Review, H1 2013
3/28/2013 | published by: Global Markets Direct
Other Hematological Disorders – Pipeline Review, H1 2013 Summary Global Markets Direct’s, 'Other Hematological Disorders - Pipeline Review, H1 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for  |  read more...
$2,000.00
Competitor Analysis: Coagulation Factors
5/1/2013 | published by: La Merie Publishing
Competitor Analysis: Coagulation Factors Product description The Competitive Intelligence Report Coagulation Factors provides a competitor analysis of plasma-derived and recombinant coagulation factors for topical or systemic administration to treat hereditary or  |  read more...
$800.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - EU Analysis and Market Forecasts
4/30/2013 | published by: GlobalData
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - EU Analysis and Market Forecasts Summary In Europe, the ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of  |  read more...
$4,450.00
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts
4/30/2013 | published by: GlobalData
MediPoint: Diagnostic Cardiac Biomarkers for Acute Coronary Syndromes - APAC Analysis and Market Forecasts Summary The ACS in vitro diagnostics market is dominated by a single biomarker test, cardiac troponins. However, this market remains of high interest  |  read more...
$4,450.00